26 June 2026 in Langenbeck's Archives of Surgery
Purpose Accurate assessment of residual disease after neoadjuvant chemotherapy (NAC) is essential for surgical planning and prevention of incomplete excision. This study evaluated artificial intelligence (AI)–assisted digital breast tomosynthesis (DBT) as a decision-support tool for post-NAC assessment in breast cancer. Methods This retrospective study included 151 patients treated with NAC followed by surgery. Post-NAC DBT images were analyzed using Lunit INSIGHT DBT. An AI score threshold of 70 was used to classify patients as having low (< 70) or high (≥ 70) scores. In a paired subgroup of 70 patients, pre- and post-NAC AI scores were compared. Diagnostic performance and univariable and multivariable analyses were performed. Results The overall pathological complete response (pCR) rate was 41.1% (62/151). Patients with low AI scores had higher pCR rates than those with high scores (49.5% vs. 28.3%, p = 0.010). High AI scores were associated with persistent microcalcifications and residual ductal carcinoma in situ (p < 0.001). Overall accuracy was 58.3% and varied by molecular subtype, with higher performance in triple-negative breast cancer and limited discrimination in HR+/HER2 − tumors. In multivariable analysis, AI score showed borderline significance (p = 0.070). In the paired cohort, AI scores decreased after NAC (p < 0.001), but delta change did not differ between pCR and non-pCR groups (p = 0.877). Conclusion AI-assisted DBT may have potential complementary value as a decision-support tool for post-NAC surgical planning, particularly in triple-negative breast cancer and in cases with residual microcalcifications.
4 September 2026 in Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi
AMAÇ: Tiroid ve paratiroid cerrahileri endokrin cerrahide sıklıkla uygulanmaktadır. Bu girişimlerde Rekürren Laringeal Sinir (RLS) hasarına bağlı vokal kord paralizisi (VKP) önemli bir komplikasyondur. Bu çalışmada malignite nedeniyle total tiroidektomi ve lobektomi-paratiroidektomi sonrası RLS hasarı gelişen hastalarda ses terapisinin sonuçlarını ve ses parametrelerindeki değişimleri incelemeyi amaçlamaktadırGEREÇ VE YÖNTEM: Bu çalışma 2021–2025 yılları arasında tiroidektomi veya paratiroidektomi yapılan hastalarda postoperatif dönemde RLS hasarı ve vokal kord paralizisi gelişen 39 hasta üzerinde gerçekleştirilmiştir. Bu hastalara haftada bir kez, 45 dakika süreyle ses terapisi uygulanmıştır. Ses fonksiyonlarının değerlendirilmesinde maksimum fonasyon süresi, S/Z oranı, temel frekans, jitter, shimmer ve gürültü-harmonik oranı (NHR) ve Voice Handicap Index (VHI) ölçeği kullanılmıştır. BULGULAR: Hastalarda postoperatif erken dönemde ses parametrelerinde bozulma saptanmıştır. Ses terapisi verilerek takip edilen hastalarda tüm akustik ve aerodinamik parametrelerde kademeli iyileşme gözlenmiş olup MFS değerlerinde anlamlı artış, S/Z oranında azalma ve jitter, shimmer ile NHR değerlerinde düşüş izlenmiştir. VHI skorlarında zamanla azalma görülmüş olup, bu durum hastaların ses algısında da iyileşme olduğunu göstermiştir. Takip edilen diğer seanslarda vokal kord paralizi çeşidinde erken dönemde bazı parametrelerde anlamlı farklılıklar saptanırken, ileri seanslarda bu farkların azaldığı gözlenmiştir. SONUÇ: Rekürren laringeal sinir (RLS) hasarına bağlı vokal kord paralizisi (VKP) sonrası gelişen ses değişikliklerinin iyileşme eğiliminde olduğu söylenebilir. Postoperatif dönemde uygulanan ses terapisinin ve rehabilitasyon yaklaşımlarının ses fonksiyonlarının düzelmesine katkı sağlayabileceğini düşündürmektedir. Gözlenen iyileşmenin doğal iyileşme süreci ile değerlendirilmesi gerektiği göz önünde bulundurulmalıdır.
30 April 2025 in Medical Journal of Western Black Sea
Mirizzi syndrome (MS) is characterized by the blockage of the bile duct due to external compression caused by a large stone located in the Hartmann pouch or cystic duct of the gallbladder. These patients present with obstructive jaundice accompanied by fever and right upper quadrant pain. If it cannot be detected in the preoperative or intraoperative period, it may cause biliary tract injuries during surgery. In this case, a 60-year-old female patient who complains of abdominal pain, jaundice, nausea, and vomiting and was diagnosed with cholelithiasis and choledocholithiasis is presented. The diagnosis of Mirizzi syndrome was clarified with MR Cholangiopancreatography (MRCP) after the procedure of endoscopic retrograde cholangiopancreatography (ERCP) for choledochal stone that was unsuccessful. Cholecystectomy, common bile duct (CBD) exploration, and T-tube drainage performed to the patient for whom surgical intervention was decided. The postoperative period ended uneventfully.
28 January 2026 in World Journal of Surgical Oncology
Background: Intraoperative ultrasound (IO-USG) may optimize axillary management in breast cancer surgery. This study evaluated IO-USG’s dual role in preventing unnecessary axillary lymph node dissection (ALND) and identifying additional nodal metastases missed by sentinel lymph node biopsy (SLNB). Methods: This retrospective cohort study included 314 consecutive patients with invasive breast cancer who underwent SLNB with IO-USG evaluation between January 2019 and December 2023. IO-USG was performed after SLNB to identify suspicious non-sentinel nodes. Patients were categorized into SLNB-only, targeted axillary dissection (TAD), or ALND based on combined SLNB and IO-USG findings. Results: Of 314 patients, 113 (36%) received neoadjuvant chemotherapy and 201 (64%) underwent upfront surgery. Final surgical management comprised SLNB-only in 244 (77.7%), TAD in 46 (14.7%), and ALND in 24 (7.6%) patients. Among 89 SLNB-positive patients, 68 (76.4%) avoided ALND through IO-USG guidance. IO-USG identified additional axillary metastases in 4 of 225 SLNB-negative patients (1.8%). Molecular subtype analysis revealed no IO-USG positivity in triple-negative cases (0/25), while HR+/HER2- tumors comprised 82.6% of IO-USG-positive cases. At a median follow-up of 33.2 months, no axillary recurrences occurred. Conclusion: IO-USG may support personalized axillary management, helping avoid ALND in 76.4% of node-positive patients while identifying additional axillary metastases in 1.8% of SLNB-negative cases. As a complementary technique to standard SLNB, it appears to provide selective utility based on tumor biology. Trial registration: Not applicable.